rs756461496
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_018972.4(GDAP1):c.1019dupT(p.Arg341GlnfsTer12) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,896 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_018972.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251430Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135890
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461796Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727216
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152100Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74296
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease Pathogenic:1
- -
Inborn genetic diseases Pathogenic:1
The c.1019dupT variant, located in coding exon 6 of the GDAP1 gene, results from a duplication of T at nucleotide position 1019, causing a translational frameshift with a predicted alternate stop codon (p.R341Qfs*12). This alteration occurs at the 3' terminus of the GDAP1 gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 3% of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this variant is expected to be causative of a spectrum of autosomal recessive Charcot-Marie-Tooth (CMT) diseases including CMT recessive intermediate type A (CMTRIA), axonal CMT disease with vocal cord paresis, and CMT type 4A (CMT4A) when present along with a second pathogenic variant on the other allele; however, its clinical significance for autosomal dominant axonal CMT disease, type 2K (CMT2K) is unclear. -
Charcot-Marie-Tooth disease type 4A Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg341Glnfs*12) in the GDAP1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 18 amino acid(s) of the GDAP1 protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with autosomal recessive neuropathy (internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant has been reported in individual(s) with autosomal dominant neuropathy (PMID: 25614874; internal data); however, the role of the variant in this condition is currently unclear. ClinVar contains an entry for this variant (Variation ID: 406140). For these reasons, this variant has been classified as Pathogenic. -
Charcot-Marie-Tooth disease axonal type 2K Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at